Subjective tolerability of antipsychotic medications and the emerging science of subjective tolerability disorders

被引：9

作者：

Awad, A. George ^{[1
,2
,3
]}

机构：

[1] Univ Toronto, Dept Psychiat, Toronto, ON M5S 1A1, Canada

[2] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada

[3] Humber River Reg Hosp, Toronto, ON, Canada

来源：

EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH | 2010年 / 10卷 / 01期

关键词：

DRUG-THERAPY; NEUROLEPTIC TREATMENT; DOPAMINE DEPLETION; SCHIZOPHRENIA; PREDICTION; HYPOTHESIS; DEPRESSION; EXPERIENCE; DYSPHORIA; SCALE;

D O I：

10.1586/ERP.10.2

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

引用

页码：1 / 4

页数：4

共 42 条

[1]

[Anonymous], 2009, Guidance for industry: Patient-Reported outcome measures: Use in medical product development to support labeling claims

[2]

[Anonymous], PREDICTION NEUROLEPT, DOI DOI 10.1007/978-3-7091-6636-9_10

[3]

Awad A G., 2005, Journal of Dual Diagnosis, V1, P83, DOI [DOI 10.1300/J374v01n02_06, 10.1300/j374v01n02_06 of, DOI 10.1300/J374V01N02_06OF]

[4] Assessment of the patient's subjective experience in acute neuroleptic treatment: Implications for compliance and outcome [J].

Awad, AG ;

Voruganti, LNP ;

Heslegrave, RJ ;

Hogan, TP .

INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1996, 11 :55-59

[5] EARLY TREATMENT EVENTS AND PREDICTION OF RESPONSE TO NEUROLEPTICS IN SCHIZOPHRENIA [J].

AWAD, AG ;

HOGAN, TP .

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1985, 9 (5-6) :585-588

[6] SUBJECTIVE RESPONSE TO NEUROLEPTICS IN SCHIZOPHRENIA [J].

AWAD, AG .

SCHIZOPHRENIA BULLETIN, 1993, 19 (03) :609-618

[7] DRUG-THERAPY IN SCHIZOPHRENIA - VARIABILITY OF OUTCOME AND PREDICTION OF RESPONSE [J].

AWAD, AG .

CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 1989, 34 (07) :711-720

[8]

Awad AG, 2000, ZUKUNFTSPERSPKTIVEN, P21

[9]

AWAD AG, 1999, MANAGING SIDE EFFECT, P1

[10]

BARTKO G, 1987, J CLIN PSYCHIAT, V48, P363

← 1 2 3 4 5 →